Psilocybin with psychological support for anhedonia in treatment-resistant depression: a randomised controlled pilot trial
Effects of psilocybin with psychological support on anhedonia in treatment-resistant depression: A randomized controlled pilot trial.
A randomised, double-blinddouble-blindA study in which neither participants nor the researchers assessing them are told who received which treatment.Open the glossary, placebo-controlledplacebo-controlledA study that compares the treatment with an inactive or low-dose look-alike, called a placebo.Open the glossary pilot trial in 20 participants with treatment-resistant major depressive disorder found no statistically significant between-group difference in anhedonia at the primary week 1 endpoint, with a DARS change difference of 11.2 (95% CI, -1.0 to 23.3; p = 0.073) for psilocybin 25 mg versus 1 mg, both given with psychological support.
Key facts
- Kind of item
- Papers
- Compound
- Psilocybin
- Condition
- Depression
- Jurisdiction
- United States
- Participants
- 20 participants (as written in the text)
- Source
- Europe PMC: new psychedelic research papers (europepmc.org)
- Published
- Original
- Read it at europepmc.org
How this summary was made
The summary was written by an AI model from the linked source, and a model scored the item against this site's editorial criteria. The facts above come from the item's topics and from identifiers written out in the stored text. Anything not found there is left out, so a missing row means not stated, not no. Read the original before relying on any detail. Editorial method
Source: Europe PMC: new psychedelic research papers · europepmc.org
Connected to
- Kind of item
- Papers
- Compound
- Psilocybin
- Condition
- Depression
- Jurisdiction
- United States